Cargando…
Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling
Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer development. COPD induces activation of hypoxia-induced signaling, causing remodeling of surrounding microenvironmental cells also modulating the release and cargo of their extracellular vesicles (EVs). We aimed to evaluat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576796/ https://www.ncbi.nlm.nih.gov/pubmed/37838700 http://dx.doi.org/10.1038/s41419-023-06212-1 |
_version_ | 1785121193292988416 |
---|---|
author | Petraroia, Ilaria Ghidotti, Patrizia Bertolini, Giulia Pontis, Francesca Roz, Luca Balsamo, Melissa Suatoni, Paola Pastorino, Ugo Ferretti, Anna Maria Sozzi, Gabriella Fortunato, Orazio |
author_facet | Petraroia, Ilaria Ghidotti, Patrizia Bertolini, Giulia Pontis, Francesca Roz, Luca Balsamo, Melissa Suatoni, Paola Pastorino, Ugo Ferretti, Anna Maria Sozzi, Gabriella Fortunato, Orazio |
author_sort | Petraroia, Ilaria |
collection | PubMed |
description | Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer development. COPD induces activation of hypoxia-induced signaling, causing remodeling of surrounding microenvironmental cells also modulating the release and cargo of their extracellular vesicles (EVs). We aimed to evaluate the potential role of circulating EVs from COPD subjects in lung cancer onset. Plasma-EVs were isolated by ultracentrifugation from heavy smoker volunteers with (COPD-EVs) or without (heavy smoker-EVs, HS-EV) COPD and characterized following MISEV guidelines. Immortalized human bronchial epithelial cells (CDK4, hTERT-HBEC3-KT), genetically modified with different oncogenic alterations commonly found in lung cancer (sh-p53, KRAS(V12)), were used to test plasma-EVs pro-tumorigenic activity in vitro. COPD-EVs mainly derived from immune and endothelial cells. COPD-EVs selectively increased the subset of CD133(+)CXCR4(+) metastasis initiating cells (MICs) in HBEC-sh-p53-KRAS(V12high) cells and stimulated 3D growth, migration/invasion, and acquisition of mesenchymal traits. These effects were not observed in HBEC cells bearing single oncogenic mutation (sh-p53 or KRASV12). Mechanistically, hypoxia-inducible factor 1-alpha (HIF-1α) transferred from COPD-EVs triggers CXCR4 pathway activation that in turn mediates MICs expansion and acquisition of pro-tumorigenic effects. Indeed, HIF-1α inhibition or CXCR4 silencing prevented the acquisition of malignant traits induced by COPD-EVs alone. Hypoxia recapitulates the effects observed with COPD-EVs in HBEC-sh-p53-KRAS(V12high) cells. Notably, higher levels of HIF-1α were observed in EVs from COPD subjects who subsequently developed cancer compared to those who remained cancer-free. Our findings support a role of COPD-EVs to promote the expansion of MICs in premalignant epithelial cells through HIF-1α-CXCR4 axis activation thereby potentially sustaining lung cancer progression. |
format | Online Article Text |
id | pubmed-10576796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105767962023-10-16 Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling Petraroia, Ilaria Ghidotti, Patrizia Bertolini, Giulia Pontis, Francesca Roz, Luca Balsamo, Melissa Suatoni, Paola Pastorino, Ugo Ferretti, Anna Maria Sozzi, Gabriella Fortunato, Orazio Cell Death Dis Article Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer development. COPD induces activation of hypoxia-induced signaling, causing remodeling of surrounding microenvironmental cells also modulating the release and cargo of their extracellular vesicles (EVs). We aimed to evaluate the potential role of circulating EVs from COPD subjects in lung cancer onset. Plasma-EVs were isolated by ultracentrifugation from heavy smoker volunteers with (COPD-EVs) or without (heavy smoker-EVs, HS-EV) COPD and characterized following MISEV guidelines. Immortalized human bronchial epithelial cells (CDK4, hTERT-HBEC3-KT), genetically modified with different oncogenic alterations commonly found in lung cancer (sh-p53, KRAS(V12)), were used to test plasma-EVs pro-tumorigenic activity in vitro. COPD-EVs mainly derived from immune and endothelial cells. COPD-EVs selectively increased the subset of CD133(+)CXCR4(+) metastasis initiating cells (MICs) in HBEC-sh-p53-KRAS(V12high) cells and stimulated 3D growth, migration/invasion, and acquisition of mesenchymal traits. These effects were not observed in HBEC cells bearing single oncogenic mutation (sh-p53 or KRASV12). Mechanistically, hypoxia-inducible factor 1-alpha (HIF-1α) transferred from COPD-EVs triggers CXCR4 pathway activation that in turn mediates MICs expansion and acquisition of pro-tumorigenic effects. Indeed, HIF-1α inhibition or CXCR4 silencing prevented the acquisition of malignant traits induced by COPD-EVs alone. Hypoxia recapitulates the effects observed with COPD-EVs in HBEC-sh-p53-KRAS(V12high) cells. Notably, higher levels of HIF-1α were observed in EVs from COPD subjects who subsequently developed cancer compared to those who remained cancer-free. Our findings support a role of COPD-EVs to promote the expansion of MICs in premalignant epithelial cells through HIF-1α-CXCR4 axis activation thereby potentially sustaining lung cancer progression. Nature Publishing Group UK 2023-10-14 /pmc/articles/PMC10576796/ /pubmed/37838700 http://dx.doi.org/10.1038/s41419-023-06212-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Petraroia, Ilaria Ghidotti, Patrizia Bertolini, Giulia Pontis, Francesca Roz, Luca Balsamo, Melissa Suatoni, Paola Pastorino, Ugo Ferretti, Anna Maria Sozzi, Gabriella Fortunato, Orazio Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling |
title | Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling |
title_full | Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling |
title_fullStr | Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling |
title_full_unstemmed | Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling |
title_short | Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling |
title_sort | extracellular vesicles from subjects with copd modulate cancer initiating cells phenotype through hif-1α shuttling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576796/ https://www.ncbi.nlm.nih.gov/pubmed/37838700 http://dx.doi.org/10.1038/s41419-023-06212-1 |
work_keys_str_mv | AT petraroiailaria extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT ghidottipatrizia extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT bertolinigiulia extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT pontisfrancesca extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT rozluca extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT balsamomelissa extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT suatonipaola extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT pastorinougo extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT ferrettiannamaria extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT sozzigabriella extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling AT fortunatoorazio extracellularvesiclesfromsubjectswithcopdmodulatecancerinitiatingcellsphenotypethroughhif1ashuttling |